top of page

OUR JOURNEY

Biomonadic started as an aspiration to enable scaling and greater patient access for cell and gene therapies, antibidoes, an industry that is the future of cures for cancer, aging, and a number of other diseases

OUR MISSION

Redefining manufacturing for cell culture bioprocesses

Our mission is to democratize access to lifesaving therapies, through leveraging AI to optimize the manufacturing process for these therapies, enabling their production at greater quality and speed and lower cost. 

Vysak Venmateswaran - Founder and CEO headshot

Vysak Venkateswaran
CEO
Vysak is a cancer immunologist turned engineer, AI/IoT product manager and biotech founder with experience building large scale architectures to optimize industrial manufacturing. Vysak began his career exploring T cell maturation in the context of cancer metastasis and built experience in the technology industry developing smart manufacturing platforms for the Fortune 100. Vysak is a multidisciplinary thinker and leader, with experience working in multiple industries (biotech, smart manufacturing, smart transit, energy, e-commerce) and has technical experience as a scientist and software engineer. Vysak studied biology and biotechnology at Duke and Northwestern and is currently pursuing his MBA at UC Berkeley.

image.png

Will Lunden
CTO
Will has a background in reinforcement learning and optimizing complex scientific architectures. Will worked on a small team to develop some of the world's first compact optical atomic clocks to be demonstrated outside of a laboratory environment. Running specialized deep learning-backed control software which he developed, these complex systems ran autonomously aboard an active naval vessel at sea for over 3 weeks. Will studied astronomy and physics at SUNY Stony Brook and received his PhD in atomic physics from MIT.

Our Journey So Far

MAR 2023

BIOMONADIC IS FOUNDED

Biomonadic started as a UC Berkeley startup spun out of the STEP incubator program

APR 2023

UC Berkeley Skydeck Pad13 Incubator

Biomonadic was accepted into Berkeley's Skydeck Pad13 incubator cohort for summer 2023

SEP 2023

MIT Engine Blueprint Incubator

Biomonadic entered the Engine's MIT-affiliated Blueprint incubator program 

bottom of page